你是否了解到慢性阻塞性肺病（COPD）这一病症？全球有数百万患者因这类呼吸系统疾病而备受折磨，严重影响生活质量。近日，和铂医药-B（02142）宣布其针对慢性阻塞性肺病的新型全人源单克隆抗体HBM9378/SKB378获得了中国国家药品监督管理局（NMPA）的新药研究申请（IND）批准，这一消息在医疗健康领域引起了广泛关注。这一新药的研发，或许能为COPD患者带来新的希望。

People with respiratory diseases, such as chronic obstructive pulmonary disease (COPD) or severe asthma, can be particularly susceptible to the effects of cold weather, finding themselves shorter ...

Older adults typically develop COPD compared to younger age groups. The longer you’re exposed to certain risk factors, including smoking, the higher the chance of developing this group of lung ...

A score that measures airflow into and out of your lungs can help diagnose COPD and determine the best treatments. Share on Pinterest PongMoji/Getty Images Spirometry is an important tool for ...

You must go to a doctor to know for sure whether you have COPD. That’s because there are things to consider for a diagnosis. Some people have asthma and COPD at the same time. If you have ...

You have full access to this article via your institution. Available treatments for COPD are mainly palliative, and there are no therapies available that halt the decline in lung function or the ...

The problem with COPD is you have obstruction to air flow, so most patients have a chronic cough, have some shortness of breath, have some wheezing. And periodically they will have what we call an ...

The diagnosis of COPD can be frustrating for both the patient and the physician, especially when a patient is identified as having the frequent-exacerbation phenotype. Counseling these patients is ...

In conclusion, COPD is a global disease, with increasing prevalence and health-related impact. The loss of FEV 1 may be slowing down, but what is really needed is an intervention that improves it ...

People with COPD also experience multiple comorbidities. Metabolic syndrome – when a person has diabetes, obesity, high cholesterol and high blood pressure – is a common comorbidity in people ...

Additional research addressing the connection between chronic obstructive pulmonary disease (COPD) and metabolic syndrome is needed to improve holistic patient care, according to a new editorial.